Other languages HYTN Innovations Inc.

Equities

HYTN

CA40443L1040

Market Closed - Canadian Securities Exchange Other stock markets 15:47:41 2024-06-07 EDT			5-day change	1st Jan Change
0.395 ^CAD	+2.60%		+12.86%	+464.29%

05-30	HYTN Innovations Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
03-26	HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

HYTN Innovations Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-30
HYTN Innovations Inc.: HYTN begrüßt Empfehlung zur Neueinstufung von Cannabis in den USA und ortet Wachstumschancen	05-01
HYTN Innovations Inc.: HYTN erneuert GMP-Stabilitätsprogramme und setzt Branchenmaßstab	04-22
HYTN Innovations Inc.: HYTN erwartet Audit von Health Canada zur Verbesserung seiner GMP-Fähigkeiten	04-09
HYTN Innovations Inc.: HYTN stellt Unternehmens-Update bereit und erläutert neue globale Ausrichtung	04-03
HYTN Innovations Inc.: HYTN sichert sich GMP-Zertifizierung	03-21
HYTN Innovations Inc.: HYTN absolviert erfolgreichen PIC/S-GMP-Audit und stellt Weichen für globale Expansion	03-04
HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-29
HYTN Innovations Inc. Announces Expansion of 100 MG Nano Shot Citrus to Western Canada	02-20
HYTN Innovations Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	01-28
HYTN Innovations Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-28
HYTN Innovations Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-29
Hytn Innovations Inc. Announces Board Resignations	23-04-12
HYTN Innovations Inc. Expands its Controlled Drugs and Substances Dealers License to Include Mdma and Ketamine	23-03-02
HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-27
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development	23-02-23
HYTN Innovations Inc. Auditor Raises 'Going Concern' Doubt	23-01-29
HYTN Innovations Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-01-29
Hytn Innovations Inc. Announces That Its Wholly Owned Subsidiary, Hytn Cannabis Inc. Enters into Sales, Distribution and Marketing Agreement with Rose Lifescience Inc	22-10-24
Hytn Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products	22-09-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages HYTN Innovations Inc.

Equities

HYTN

CA40443L1040

Other languages

Filters